ストックスクリーナーアプリを入手
5.72
1.78%
0.10
アフターアワーズ：
5.75
0.03
+0.52%
前日終値:
$5.62
開ける：
$5.54
24時間の取引高:
2.01M
Relative Volume:
0.64
時価総額：
$697.86M
収益：
$58.36M
当期純損益:
$-25.72M
株価収益率:
-15.71
EPS:
-0.3641
ネットキャッシュフロー:
$-24.91M
1週間 パフォーマンス:
+6.12%
1か月 パフォーマンス:
-18.75%
6か月 パフォーマンス:
+151.98%
1年 パフォーマンス:
+26.83%
1日の値動き範囲:
$5.53
$5.7858
1週間の範囲:
$5.35
$6.168
52週間の値動き範囲:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
名前
Aquestive Therapeutics Inc
セクター
電話
908-941-1900
住所
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
5.72 | 685.66M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-28 | 開始されました | Raymond James | Outperform |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-04-22 | 開始されました | H.C. Wainwright | Buy |
| 2019-01-03 | 開始されました | Lake Street | Buy |
| 2018-08-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-08-20 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Aquestive Therapeutics Inc (AQST) 最新ニュース
Why Aquestive Therapeutics Inc. stock is favored by top institutionsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Can Aquestive Therapeutics Inc. stock sustain revenue growthPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Aquestive Therapeutics Inc. stock momentum explainedMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Officer Kraus Files To Sell 53,100 Of Aquestive Therapeutics Inc [AQST] - TradingView
Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51 - Nasdaq
Will Aquestive Therapeutics Inc. bounce back from current supportLayoff News & AI Based Buy and Sell Signals - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges - MSN
Aquestive Therapeutics (NASDAQ:AQST) Updates Amid Dow Jones Industrial Average - Kalkine Media
Why Aquestive Therapeutics Inc. stock is favored by pension fundsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors - simplywall.st
Using R and stats models for Aquestive Therapeutics Inc. forecastingInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Can technical indicators confirm Aquestive Therapeutics Inc.’s reversalTrade Risk Summary & Weekly High Potential Alerts - newser.com
Will Aquestive Therapeutics Inc. stock attract more institutional investorsWeekly Gains Report & Growth Focused Entry Reports - Fundação Cultural do Pará
Will Aquestive Therapeutics Inc. stock outperform tech sector in 20252025 Trading Volume Trends & Weekly Hot Stock Watchlists - Fundação Cultural do Pará
Aquestive Therapeutics Q3 2025 Earnings Preview - MSN
Will Aquestive Therapeutics Inc. stock gain from strong economy2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Jim Cramer on Aquestive Therapeutics: “I Think It’s a Very Interesting Spec” - Insider Monkey
Aquestive Therapeutics Inc (AQST) 財務データ
収益
当期純利益
現金流量
EPS
Aquestive Therapeutics Inc (AQST) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Option Exercise |
3.10 |
25,000 |
77,568 |
308,346 |
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Sale |
7.01 |
67,575 |
473,701 |
240,771 |
| Kraus Carl N | Chief Medical Officer |
Oct 15 '25 |
Sale |
7.00 |
20,272 |
141,904 |
282,475 |
| Boyd Peter E. | See Remarks |
Oct 15 '25 |
Sale |
7.00 |
10,000 |
70,000 |
268,323 |
3.24%
大文字化:
|
ボリューム (24 時間):